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ressElmer 
A Neuropsychiatric Presentation of Seronegative 
Autoimmune Encephalitis: A Case Report
Muhammad Fahmi Ismaila, d, Eimer Moloneyb, Daniel J. Costellob, 
 Brian J. Sweeneyb, Eugene M. Cassidyc
Abstract
Autoimmune encephalitis with negative paraneoplastic, infectious 
and serology markers poses a considerable diagnostic and therapeutic 
challenge. We described a case with neuropsychiatric presentation of 
seronegative autoimmune encephalitis. Paraneoplastic, infectious and 
metabolic etiologies were excluded. The patient responded to immu-
notherapy and achieved full remission.
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Introduction
Autoimmune encephalitis is an acute inflammation of the brain 
secondary to autoimmune process that manifests as seizures, 
cognitive impairment, and neuropsychiatric symptoms [1]. Se-
ronegative autoimmune encephalitis is a subgroup of encepha-
litis with suspected immunologic origin but with no identifi-
able pathogenic autoantibody [1].
Case Report
A 20-year-old female with no previous medical or psychiatric 
history was brought to the hospital following a cluster of epi-
leptic seizures. Collateral history obtained suggested changes 
in personality and behavior from pre-morbid baseline which 
include disorganized behavior, increasing agitation and poor 
coping over a 4-week period. A brain CT was normal. An elec-
troencephalography (EEG) showed moderately diffuse slow-
ing. Cerebrospinal fluid (CSF) analysis revealed a lymphocytic 
pleocytosis with glucose and protein within the normal range. 
Her serum and CSF were sent to screen for infectious, inflam-
matory, autoimmune and metabolic cause of encephalitis which 
were all subsequently negative (Table 1). She was commenced 
on levetiracetam and intravenous acyclovir (Fig. 1).
On day 2, her symptoms deteriorated rapidly. She evolved 
into a state of mutism, unpredictable episodes of extreme agi-
tation and a dramatic deterioration in social conduct. Further 
EEG studies and brain imaging by magnetic resonance imag-
ing (MRI) were unremarkable. She was commenced on intra-
venous methylprednisolone on day 2.
On day 3, her symptoms deteriorated further. She became 
increasingly confused with intermittent episodes of psychomo-
tor excitation and abrupt stereotyped movement. She was as-
sessed by the liaison psychiatry team. On mental state exami-
nation, the patient was sitting abnormally still with minimal 
interaction. She was verbally unresponsive to majority of the 
questions. She had a fixed stare with occasional shifts of at-
tention. There was no evidence of posturing. When she did 
verbalize, there was evidence of intermittent echolalia. There 
was evidence of abrupt repetitive motor activity, i.e. abruptly 
standing on the bed followed by tumbling forwards. There was 
evidence of automatic obedience and ambitendency, i.e. she 
was observed to be stuck in mid-way from standing to sitting 
position for several minutes. She scored 16 out 69 on a Bush-
Francis catatonia rating scale.
Her condition deteriorated further on day 12 with worsen-
ing agitation which required sedation to manage the challeng-
ing behavior due to risk of self-injury. She was commenced 
on regular olanzapine at this stage. Methyprednisolone was 
stopped after 5 days and was switched to oral prednisolone. 
On day 9, she was commenced on intravenous immunoglobu-
lins for 5 days with no response. On day 15, she developed 
symptoms of autonomic instability which include episodes of 
bradycardia, tachycardia, and hypoventilation. She was then 
transferred to the intensive care unit (ICU) in which she re-
quired intubation and full assisted ventilation. In ICU, she had 
five sessions of plasmapheresis with a trial of weekly rituxi-
mab. She responded well to the combination of plasmapheresis 
and rituximab. There was a difficulty in weaning off sedation 
initially due to her challenging behavior which required high-
dose olanzapine. She gradually improved and was transferred 
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to the ward after 32 days in ICU. On re-assessment, she had 
residual emotional lability with poor abstraction. She received 
full score on Addenbrooke’s cognitive assessment (ACE-R). 
She was discharged from hospital on day 62 on prophylactic 
antiviral, reducing prednisolone, levetiracetam and olanzapine. 
She was reviewed 10 days post-discharge. Her mental state was 
stable, and had improved concentration with normal behavior. 
The olanzapine and prednisolone were gradually weaned.
Discussion
In 60% of cases of encephalitis, the cause remains unknown 
[2]. Certain types of autoimmune encephalitis can be diag-
nosed by identifying a specific antibody in the serum or CSF 
(i.e. NMDAR, AMPAR, GABABR, LGI1, and CASPR2) [2]. 
New antibodies against neuronal cell surface or synaptic pro-
teins have been continuously expanded for the last number of 
years [2].
Most autoimmune encephalitis is associated with CSF 
lymphocytic pleocytosis [3]. The mainstay of treatment for 
autoimmune encephalitis is immunotherapy which includes 
steroids, intravenous immunoglobulins, biologics and plasma-
pheresis [4]. Some have proposed a specific treatment pathway 
in those with suspected autoimmune encephalitis with nega-
tive auto-antibodies [5].
Table 1.  List of Investigations and Results
Test Day Results
Imaging, EEG and CSF analysis
  Brain CT 1 No abnormalities detected
  Brain MRI 2, 4 No abnormalities detected
  Pelvic US 7 No abnormalities detected
  EEG 1, 2 Moderate to severe encephalopathy, no delta  
brush
  CT TAP 3 No abnormalities detected
  CTPA 14 No abnormalities detected
  CSF microscopy 1 WCC = 78/mm3 (100% lymphocytes), 
glucose and total protein = normal range
  CSF microscopy 6 WCC = 7/mm3 (no differentials), glucose 
and total protein = normal range
Infection markers
  CSF viral screen (HSV1, HSV2, measles RNA, mumps RNA, VZV,  
enterovirus RNA)
1, 6, 17, 22 Negative
  CSF culture and sensitivity 1, 6, 17, 22 Negative
  Anti-extractable nuclear antibody 4 Negative
  Syphilis total antibody 4 Negative
  Anti-streptolysin (ASO) titer 4 Negative
  Hepatitis C antibodies, hepatitis B surface antigens 13 Negative
  Lyme disease serology 15, 53 Negative
Autoimmune, paraneoplastic and metabolic markers
  Anti-Yo and anti-Hu 9 Negative
  CEA19.9, CA125, CA15.3 9 Negative
  Prophyria screen 20 Negative
  Ceruplasmin and copper 4 Normal range
  CSF and serum NMDA-R, VGKC, AMPAR-a, 
AMPAR-b, GABA-b receptor antibodies
4 Negative
  Anti-neutrophil cyto ab, anti-nuclear ab, anti-mitochondrial ab, anti-
smooth mucle ab, anti-gastric parietal cell ab, anti-thyroid peroxidase ab
4 Negative
  CSF immunoglobulin (IgG) 17, 22 Intrathecal IgG elevated, no oligoclonal  
bands detected
MRI: magnetic resonance imaging; EEG: electroencephalography; US: ultrasound; CT TAP: CT thorax, abdomen, and pelvis; CTPA: CT pulmonary 
angiography; CSF: cerebrospinal fluid; WCC: white cell count; HSV: herpes simplex virus; RNA: ribonucleic acid; VZV: varicella zoster virus.
Articles © The authors   |   Journal compilation © J Med Cases and Elmer Press Inc™   |   www.journalmc.org470
Seronegative Autoimmune Encephalitis J Med Cases. 2015;6(10):468-471
Fi
gu
re
 1
. T
im
el
in
e 
of
 th
e 
ca
se
 re
po
rt.
 
Articles © The authors   |   Journal compilation © J Med Cases and Elmer Press Inc™   |   www.journalmc.org 471
Ismail et al J Med Cases. 2015;6(10):468-471
Grant Support
None.
Conflict of Interest
None.
References
1. Najjar S, Pearlman D, Devinsky O, Najjar A, Nadkarni 
S, Butler T, Zagzag D. Neuropsychiatric autoimmune en-
cephalitis without VGKC-complex, NMDAR, and GAD 
autoantibodies: case report and literature review. Cogn 
Behav Neurol. 2013;26(1):36-49.
2. Armangue T, Leypoldt F, Dalmau J. Autoimmune en-
cephalitis as differential diagnosis of infectious encepha-
litis. Curr Opin Neurol. 2014;27(3):361-368.
3. Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner 
L, Collins A, et al. Anti-NMDA receptor encephalitis: 
report of ten cases and comparison with viral encephali-
tis. Eur J Clin Microbiol Infect Dis. 2009;28(12):1421-
1429.
4. Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-
D-aspartate-receptor encephalitis: diagnosis, optimal 
management, and challenges. Ther Clin Risk Manag. 
2014;10:517-525.
5. Ahmad SA, Archer HA, Rice CM, Gerhand S, Bradley 
M, Wilkins A. Seronegative limbic encephalitis: case re-
port, literature review and proposed treatment algorithm. 
Pract Neurol. 2011;11(6):355-361.
